Orphan receptor GPR158 controls stress-induced depression

Author:

Sutton Laurie P1ORCID,Orlandi Cesare1,Song Chenghui1ORCID,Oh Won Chan2,Muntean Brian S1,Xie Keqiang1,Filippini Alice3,Xie Xiangyang1,Satterfield Rachel2,Yaeger Jazmine D W45,Renner Kenneth J45,Young Samuel M2678ORCID,Xu Baoji1,Kwon Hyungbae29,Martemyanov Kirill A1ORCID

Affiliation:

1. Department of Neuroscience, The Scripps Research Institute, Jupiter, United States

2. Max Planck Florida Institute for Neuroscience, Jupiter, United States

3. Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy

4. Center for Brain and Behavior Research, University of South Dakota, Vermillion, United States

5. Department of Biology, University of South Dakota, Vermillion, United States

6. Department of Anatomy and Cell Biology, University of Iowa, Iowa, United States

7. Aging Mind and Brain Initiative, University of Iowa, Iowa, United States

8. Department of Otolaryngology, Carver College of Medicine, University of Iowa, Iowa, United States

9. Max Planck Institute of Neurobiology, Martinsried, Germany

Abstract

Stress can be a motivational force for decisive action and adapting to novel environment; whereas, exposure to chronic stress contributes to the development of depression and anxiety. However, the molecular mechanisms underlying stress-responsive behaviors are not fully understood. Here, we identified the orphan receptor GPR158 as a novel regulator operating in the prefrontal cortex (PFC) that links chronic stress to depression. GPR158 is highly upregulated in the PFC of human subjects with major depressive disorder. Exposure of mice to chronic stress also increased GPR158 protein levels in the PFC in a glucocorticoid-dependent manner. Viral overexpression of GPR158 in the PFC induced depressive-like behaviors. In contrast GPR158 ablation, led to a prominent antidepressant-like phenotype and stress resiliency. We found that GPR158 exerts its effects via modulating synaptic strength altering AMPA receptor activity. Taken together, our findings identify a new player in mood regulation and introduce a pharmacological target for managing depression.

Funder

National Institute of Mental Health

National Heart, Lung, and Blood Institute

National Institute on Drug Abuse

National Institute on Deafness and Other Communication Disorders

University of Iowa

Max-Planck-Gesellschaft

Canadian Institutes of Health Research

Publisher

eLife Sciences Publications, Ltd

Subject

General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3